Safety, feasibility and therapeutic activity of intrapleural autologous lymphocyte conditioned medium followed by systemic recombinant interleukin-2 and interferon-alpha in a patient with malignant pleural mesothelioma.
Duensing
S
S
Dept. of Hematology and Oncology, Medizinische Hochschule Hannover, Germany.
Hamm
H
H
Ganser
A
A
Atzpodien
J
J
D017077:Culture Media, Conditioned; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D007376:Interleukin-2 / Q000008:administration & dosage*; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008654:Mesothelioma / Q000628:therapy*; D008875:Middle Aged; D010997:Pleural Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage
D017077:Culture Media, Conditioned; D016898:Interferon-alpha; D007376:Interleukin-2; D011994:Recombinant Proteins